Key result
Carbetocin versus oxytocin trials at elective caesarean delivery require careful explanation of methodologies and analyses to ensure correct and meaningful conclusions.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Balki et al. (2023) studied this question. Carbetocin versus oxytocin trials at elective caesarean delivery require careful explanation of methodologies and analyses to ensure correct and meaningful conclusions.
Synapse has enriched 10 related papers. Consider them for comparative context: